Xuan Wang

10PUBLICATIONS
91CO-AUTHORS
Epidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseMultimorbidityEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 04, 2025
Semiparametric joint modeling to estimate the treatment effect on a longitudinal surrogate with application to chronic kidney disease trials.

Xuan Wang, Jie Zhou, Layla Parast

|Mar 28, 2025
Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer.

Xuan Wang, Ethan B Ludmir, Lee-Jen Wei

|Oct 22, 2024
Comparing Insulin Against Glucagon-Like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors, and Sodium-Glucose Cotransporter 2 Inhibitors on 5-Year Incident Heart Failure Risk for Patients With Type 2 Diabetes Mellitus: Real-World Evidence Study Using Insurance Claims.

Xuan Wang, Anna M Plantinga, Xin Xiong

|May 03, 2024
Characterization of Post-COVID-19 Definitions and Clinical Coding Practices: Longitudinal Study.

Monika Maripuri, Andrew Dey, Jacqueline Honerlaw

|Apr 15, 2022
Robust approach to combining multiple markers to improve surrogacy.

Xuan Wang, Layla Parast, Larry Han

|Dec 10, 2021
Authorship Correction: International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study.

Griffin M Weber, Harrison G Zhang, Sehi L'Yi

Pageof 2

Frequent Collaborators

4 joint publications

Tianxi Cai

3 joint publications

Layla Parast

3 joint publications

Malarkodi Jebathilagam Samayamuthu

3 joint publications

Harrison G Zhang